billHR8811Event Thursday, May 14, 2026Analyzed

Moms Matter Act

Neutral

Summary

The Moms Matter Act (HR8811) is an early-stage bill referred to committee with no authorized funding amount. It establishes a grant program for maternal mental health and substance use disorder services, but no specific companies or sectors are directly impacted at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Bill is in early legislative stage with no funding amount specified.
  • 2.No direct impact on publicly traded companies identified.
  • 3.Market impact is minimal until appropriations are passed.

Market Implications

No immediate market implications. The bill's grant program targets community health organizations, not publicly traded companies. If funded, potential indirect beneficiaries could include healthcare IT providers or telehealth companies, but no specific tickers are identifiable at this stage.

Full Analysis

The Moms Matter Act was introduced on May 14, 2026, and referred to the House Committee on Energy and Commerce. It is in the earliest legislative stage with no committee hearings or markups. The bill authorizes a grant program through HHS but does not specify a dollar amount, meaning actual funding requires a separate appropriations bill. No publicly traded companies are directly named or clearly affected by the grant program's structure. The bill focuses on community-based organizations and health professional shortage areas, not on specific corporate beneficiaries. Given the early stage and lack of funding authorization, market impact is negligible.

Key Legislators

Rep. Clarke, Yvette D. [D-NY-9]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.